Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Approved for marketing × Carcinoma, Transitional Cell × atezolizumab × Clear all

Status

Completed 13 Terminated 8 Active not recruiting 7 Recruiting 3 Withdrawn 1 Unknown 1 Approved for marketing 1

Sponsor Class

Study Type

Expanded_access 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Carcinoma, Transitional Cell 1

Interventions

enfortumab vedotin 1 atezolizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02589717 2016-11-02

An Expanded Access Study of Atezolizumab in Participants With Locally Advanced or Metastatic Urothelial Carcinoma After Failure With Platinum-Containing Chemotherapy

Genentech, Inc.

Approved for marketing

Carcinoma, Transitional Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡